EyePoint Pharmaceuticals (EYPT) Insider Trading & Ownership $6.37 -0.17 (-2.60%) Closing price 04:00 PM EasternExtended Trading$6.48 +0.11 (+1.65%) As of 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.74%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$10.10 MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$264,003.75 Get EYPT Insider Trade Alerts Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EYPT Insider Buying and Selling by Quarter EyePoint Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/20/2024Wendy F DiciccoDirectorBuy2,567$7.79$19,996.93 7/12/2024David R GuyerDirectorSell11,625$10.06$116,947.50 5/14/2024David R GuyerDirectorSell11,625$12.65$147,056.25 5/6/2024Cormorant Asset Management, LpMajor ShareholderBuy850,000$11.86$10,081,000.00 (Data available from 1/1/2013 forward) EYPT Insider Trading Activity - Frequently Asked Questions Who is on EyePoint Pharmaceuticals's Insider Roster? The list of insiders at EyePoint Pharmaceuticals includes Cormorant Asset Management, Lp, Dario A Paggiarino, David R Guyer, David Scott Jones, Ew Healthcare Partners, L.P., Michael Craig Pine, Wendy F Dicicco, and Ye Liu. Learn more on insiders at EYPT. What percentage of EyePoint Pharmaceuticals stock is owned by insiders? 4.74% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings. Which EyePoint Pharmaceuticals insiders have been buying company stock? The following insiders have purchased EYPT shares in the last 24 months: Cormorant Asset Management, Lp ($89,495,141.69), and Wendy F Dicicco ($19,996.93). How much insider buying is happening at EyePoint Pharmaceuticals? Insiders have purchased a total of 4,796,624 EYPT shares in the last 24 months for a total of $89,515,138.62 bought. Which EyePoint Pharmaceuticals insiders have been selling company stock? The following insiders have sold EYPT shares in the last 24 months: Dario A Paggiarino ($1,907,366.19), David R Guyer ($264,003.75), David Scott Jones ($43,454.41), Ew Healthcare Partners, L.P. ($4,296,673.06), Michael Craig Pine ($990,000.00), and Ye Liu ($42,060,746.22). How much insider selling is happening at EyePoint Pharmaceuticals? Insiders have sold a total of 2,653,425 EyePoint Pharmaceuticals shares in the last 24 months for a total of $49,562,243.63 sold. EyePoint Pharmaceuticals Key ExecutivesDr. Jay S. Duker M.D. (Age 65)President, CEO & Director Compensation: $848.5kDr. John B. Landis M.S. (Age 71)Ph.D., Interim Head of R&D and Director Compensation: $63.75kMr. Michael Pine (Age 47)Chief Business Officer Compensation: $764.85kMr. George O. Elston (Age 59)Executive VP & CFO Compensation: $743.86kMr. Michael J. MaciocioSenior Vice President of Manufacturing & OperationsMr. Ron I. Honig Esq.Chief Legal Officer & Company SecretaryMs. Jennifer LeonardChief People Officer & Senior VP of ITMr. David Scott Jones (Age 56)Senior VP & Chief Commercial Officer Compensation: $672.08kMs. Isabelle LefebvreChief Regulatory OfficerDr. Marcia Sellos-Moura Ph.D.Senior Vice President of Program Leadership More Insider Trading Tools from MarketBeat Related Companies TXG Insider Trades TRNS Insider Trades CTKB Insider Trades LAB Insider Trades SENS Insider Trades ALNT Insider Trades AEHR Insider Trades QSI Insider Trades QTRX Insider Trades MASS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:EYPT) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EYPT Stock Free EYPT Stock Alerts